https://www.selleckchem.com/products/AZD1480.html 6 years and 85% identified as African-American. There was no significant difference in scores prior to and following the intervention for the control group (N=58, F=1.67, p=0.19); however, a significant difference in scores was found in the treatment group (N=54, F=7.95, p<0.001). Post-hoc analysis showed a significant improvement in scores 1 day after intervention, but no difference 4-6 weeks later. Educational video intervention for low socioeconomic mothers at the time of the universal newborn hearing screen can positively increase knowledge related to hearing and language development in the short term. Pilot Study of Novel Postpartum Educational Video Intervention NCT02267265 https//clinicaltrials.gov/ct2/show/NCT02267265. Pilot Study of Novel Postpartum Educational Video Intervention NCT02267265 https//clinicaltrials.gov/ct2/show/NCT02267265. Direct oral anticoagulants (DOACs) have been proven to be effective and safe for prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). However, suboptimal adherence, variable dosing and use in patient populations that otherwise would have been excluded from clinical trials may impact the efficacy and safety profile of DOACs in a routine care setting. We compared stroke, bleeding, and mortality rates on and off therapy for standard and low-dose DOACs (apixaban, rivaroxaban, dabigatran) versus warfarin in a Canadian cohort. We also assessed persistence of DOACs compared to warfarin. We conducted six 1-1 propensity-score matched retrospective cohort analyses using Quebec health administrative databases (2011-2017). NVAF patients (≥18years) covered by the public medication insurance plan entered the cohort on the first OAC dispensation date. We excluded those with OAC use in the previous year or stroke or bleeding diagnoses in the previous two years. Folbetter bleeding profiles. Real-world use of DOACs may explain some of